PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature

Leukemia Research

Volumn 31, Issue 3, 2007, Pages 365-369

  Paydas, Semra ^a   Tanriverdi, Kahraman ^a   Yavuz, Sinan ^a   Seydaoglu, Gulsah ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Chronic leukemia; Immunotherapy; Minimal residual disease; PRAME

Indexed keywords

ANTIGEN; MESSENGER RNA; PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33846078096     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.06.022     Document Type: Article

References (16)

1. Lethe B., van der Bruggen P., Brasseur F., and Boon T. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte. Melanoma Res 7 Suppl. 2 (1997) S83-S88
2. Ikeda H., Lethe B., Lehmann F., van Baren N., Baurain J.F., de Smet C., et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6 (1997) 199-208
3. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25 (2000) 169-193
4. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29 (2002) 23-39
5. van Baren N., Chambost H., Ferrant A., Michaux L., Ikeda H., Millard I., et al. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells is expressed in acute leukemia cells. Br J Haematol 102 (1998) 1376-1379
6. Greiner J., Ringhoffer M., Simikopinko O., Szmaragowska A., Huebsch S., Maurer U., et al. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol 28 (2000) 1413-1422
7. Matsushita M., Yamazaki R., Ikeda H., and Kawakami Y. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies. Leuk Lymphoma 44 (2003) 439-444
8. Matsushta M., Ikeda H., Kizaki M., Okamoto S., Osagawara M., Ikeda Y., et al. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukemia. Br J Haematol 112 (2001) 916-926
9. Paydas S., Tanriverdi K., Yavuz S., Disel U., Baslamisli F., and Burgut R. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects. Am J Hematol 79 (2005) 257-261
10. Steinbach D., Hermann J., Viehmann S., Zintl F., and Gruhn B. Clinical implications of PRAME gene expression in childhood acute myeloid leukemia. Cancer Genet Cytogenet 133 (2002) 118-123
11. Steinbach D., Viehmann S., Zintl F., and Gruhn B. PRAME gene expression in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 138 (2002) 89-91
12. Watari K., Tojo A., Hagamura-Inone T., Nagamura F., Takeshita A., Fukishima T., et al. Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene. FEBS Lett 466 (2000) 367-371
13. Proto-Siqueira R., Falco R.P., de Souza C.A., Jose Ismael S., and Zago M.A. The expression of PRAME in chronic lymphoproliferative disorders. Leuk Res 27 (2003) 393-396
14. Abramenko I.B., Belous N.I., Kryachok I.A., Chumak A.A., Aksenova E.V., Lisovskaya E.V., et al. Expression of PRAME gene in multiple myeloma. Ter Arkh 76 (2004) 77-81
15. Raanani P., and Ben-Bassat I. Detection of minimal residual disease in acute myelogenous leukemia. Acta Haematol 112 (2004) 40-54
16. Greiner J., Ringhoffer M., Tanguchi M., Li L., Schmitt A., Shiku H., et al. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies. Int J Cancer 108 (2004) 704-711